|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of chemotherapy for breast cancer.
Reviewed August 2008
Printer friendly page
| Results 1 to 11 displayed. |
| Title: |
Single agent versus combination chemotherapy for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Using two or more chemotherapy (anti-cancer) drugs in combination rather than a single drug improves the survival of women with advanced breast cancer but has more adverse effects. Advanced (metastatic) breast cancer is cancer that has spread beyond the...
|
| Date: |
Feb 2005
|
| Title: |
Antitumour antibiotic containing regimens for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Advanced (metastatic) breast cancer is cancer that has spread beyond the breast. Treatment for metastatic disease usually involves some type of chemotherapy (anti-cancer drugs) to try to reduce the cancer. Chemotherapy drugs can either be given as a sin...
|
| Date: |
Jul 2004
|
| Title: |
Platinum containing regimens for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Advanced (metastatic) breast cancer has spread beyond the breast. Treatment usually involves chemotherapy (anti-cancer drugs) to try to reduce the cancer. Drugs can be used alone or in combination. Cisplatin and carboplatin are chemotherapy drugs contai...
|
| Date: |
Feb 2004
|
| Title: |
Taxane containing regimens for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Advanced (metastatic) breast cancer is cancer that has spread beyond the breast. Treatment usually involves chemotherapy (anti-cancer drugs) to try to reduce the cancer. Drugs can be used alone or in combination. Paclitaxel and docitaxel are chemotherap...
|
| Date: |
Feb 2005
|
| Title: |
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Of interest is whether there is any benefit to increasing the dose intensity of a regimen, particularly given the potential harm caused by more dose-intensive treatment. This review investigated the value of adding one or more chemotherapy drugs to a ch...
|
| Date: |
May 2006
|
| Title: |
Tamoxifen for early breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
'Early' breast cancer means detectable cancer that can be surgically removed. However undetected cancer cells can develop after several years and cause death. Tamoxifen improves the 10-year survival for women after breast cancer surgery but there is unc...
|
| Date: |
Nov 2000
|
| Title: |
Bisphosphonates for breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
When breast cancer has spread to the bones (bone metastases ), bisphosphonate drugs (added to anti-cancer treatment for breast cancer) can reduce pain, fractures and other bone problems. Women and men with advanced breast cancer commonly develop bone me...
|
| Date: |
Jan 2007
|
| Title: |
Multi-agent chemotherapy for early breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Early breast cancer can be removed by surgery, and for many women the chance of the cancer returning (recurrence) is small. In some women however, the cancer does return. Chemotherapy (anti-cancer drugs) is used to try to prevent this, and to try to imp...
|
| Date: |
Aug 2001
|
| Results 1 to 11 displayed. |
|